Naz Rahman

Stock Analyst at Maxim Group

(0)
# 5116
Out of 5,293 analysts
49
Total ratings
14.29%
Success rate
-45.62%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
SLXN Silexion Therapeutic...
Maintains: Buy
9 5
1.05 376.19% 2 Mar 20, 2025
SCPH scPharmaceuticals
Maintains: Buy
20 12
2.33 415.02% 3 Mar 20, 2025
VKTX Viking Therapeutics
Maintains: Buy
120 70
23.67 195.73% 5 Feb 7, 2025
NRSN NeuroSense Therapeut...
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
CING Cingulate
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 8
0.68 1076.47% 7 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.67 347.76% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 4
0.22 1718.18% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.08 4900% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.2 316.67% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
2.94 104.08% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
n/a n/a 1 Mar 31, 2021